GlassScriptPhysician profile
Ely Shapiro
NPI 1154359149
$9,544.72
in general payments reported to CMS, 2019-2025
30 companies · $1,488 in 2025
The $1,488 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,134 · 2020: $811 · 2021: $1,815 · 2022: $1,169 · 2023: $948 · 2024: $1,178 · 2025: $1,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,459 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,458.67 |
| Education | $155.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $1,217.23 | 2019-2024 | Trudi Nav Cable, Relieva Tract, Relieva Spinplus |
| Genzyme Corporation | $1,007.88 | 2019-2025 | |
| Aerin Medical INC. | $1,002.89 | 2019-2025 | |
| Intersect Ent, INC. | $918.52 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $810.91 | 2020-2025 | Dupixent |
| Inspire Medical Systems, INC. | $726.94 | 2021-2025 | Inspire |
| Medical Device Business Services, INC. | $664.75 | 2019 | |
| Stryker Corporation | $627.75 | 2019-2025 | Scopis Ent, Audion Et Dilation System, 1788 |
| Medtronic, INC. | $605.59 | 2021-2024 | Nim Vital, Pteye Parathyroid Detection System, Stealthstation S8 Platform |
| Alk-Abello, INC | $390.69 | 2019-2025 | Odactra, Grastek, Ragwitek |
| Glaxosmithkline, LLC. | $255.72 | 2019-2025 | Nucala |
| Integra Lifesciences Corporation | $246.28 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Sanofi-Aventis U.S. LLC | $217.97 | 2022-2025 | |
| Optinose US, INC. | $189.69 | 2019-2023 | |
| Hologic Sales and Service, LLC | $138.03 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $107.41 | 2019 | |
| Smith+Nephew, INC. | $96.37 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $42.81 | 2019-2020 | |
| Cochlear Americas | $41.65 | 2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Merck Sharp & Dohme LLC | $39.62 | 2021-2023 | |
| Hikma Pharmaceuticals USA | $36.49 | 2023 | Ryaltris |
| Takeda Pharmaceuticals U.S.A., INC. | $30.31 | 2021 | |
| Resmed Corp | $24.83 | 2019 | |
| Mylan Specialty L.P. | $21.27 | 2019 | |
| Phathom Pharmaceuticals, INC. | $16.96 | 2024 | Voquezna |
| Preceptis Medical, INC. | $15.02 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.01 | 2019 | |
| Kaleo, INC. | $13.48 | 2020 | |
| Pfizer INC. | $12.57 | 2019 | |
| Ethicon US, LLC | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ely Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.